Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using FAPI PET/MRI to Evaluate Prostate Cancer
Sponsor: University of Wisconsin, Madison
Summary
The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to answer is how this information can be used to better diagnose and track prostate cancer. Participants will undergo two PET/MRI scans during two research visits, each of which may last up to 2.5 hours.
Official title: Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-02-27
Completion Date
2027-01
Last Updated
2026-03-04
Healthy Volunteers
No
Interventions
FAPI
5 +/- 2 mCi of Ga-FAPI-46
Positron Emission Tomography (PET)
Undergo PET scan
Magnetic Resonance Imaging
Undergo MRI scan
Locations (1)
University of Wisconsin
Madison, Wisconsin, United States